Clinical Anatomy, EarlyView.ABSTRACT The orbicularis oculi muscle (OOc) is strongly associated with facial aging as its contraction causes the formation of crow's feet. Botulinum neurotoxin (BoNT) injection is a representative treatment targeting muscle. The aim of this study was to demonstrate the anatomical relationship between the OOc and the zygomaticus complex muscles, and ...
Jiong‐Zhen Piao +3 more
wiley +1 more source
Treatment of acute acquired concomitant esotropia
BMC Ophthalmology, 2021 Background The treatment efficacy of botulinum toxin bilateral medial rectus injections for acute acquired concomitant esotropia (AACE) in adult is not clear.
Minghua Shi +4 more
doaj +1 more source
Guideline on the use of onabotulinumtoxinA in chronic migraine. a consensus statement from the European Headache Federation [PDF]
, 2018 OnabotulinumtoxinA is being increasingly used in the management of chronic migraine (CM). Treatment with onabotulinumtoxinA poses challenges compared with traditional therapy with orally administered preventatives.
Ahmed, Fayyaz +8 more
core +3 more sources
Journal of Orthopaedic Research, EarlyView.Wistar rats underwent supraspinatus tendon tear and reconstruction. Then, rats were divided into Cage activity, Immobilization, Immobilization + Early exercise, and Immobilization + Delayed exercise groups. After 3 and 6 weeks of surgery, histological and biomechanical analyses were performed.
Haruna Misuo +7 more
wiley +1 more source
Amylase release from streptolysin O-permeabilized pancreatic acinar cells. Effects of Ca2+, guanosine 5'-[gamma-thio]triphosphate, cyclic AMP, tetanus toxin and botulinum A toxin [PDF]
, 1992 The molecular requirements for amylase release and the intracellular effects of botulinum A toxin and tetanus toxin on amylase release were investigated using rat pancreatic acinar cells permeabilized with streptolysin O.
Ahnert-Hilger, G. +4 more
core
Cost-Effectiveness of Treating Upper Limb Spasticity Due to Stroke with Botulinum Toxin Type A: Results from the Botulinum Toxin for the Upper Limb after Stroke (BoTULS) Trial [PDF]
, 2012 Stroke imposes significant burdens on health services and society, and as such there is a growing need to assess the cost-effectiveness of stroke treatment to ensure maximum benefit is derived from limited resources.
Christopher Price +16 more
core +3 more sources
Toxic megacolon: A rare presentation and novel treatment
JPGN Reports, EarlyView.Abstract A 14‐year‐old male presented with toxic megacolon (TM). Stool culture and rectal biopsies ruled out Clostridium difficile infection and Hirschsprung disease, respectively. Anorectal manometry ruled out anal achalasia as rectoanal inhibitory reflex elicited a normal resting pressure.
Adrienne P. Davis +3 more
wiley +1 more source
Treatment of chronic pain associated with nocturnal bruxism with botulinum toxin. A prospective and randomized clinical study [PDF]
, 2017 To evaluate the role of botulinum toxin type A (BTX-A) in the treatment of pain associated with nocturnal bruxism. Fifty subjects reporting nocturnal bruxism were recruited for a randomized clinical trial. Twenty five bruxers were injected with botulinum
Al Wayli, Hessa
core +1 more source
Feasibility and clinical value of pyloric functional luminal imaging probe in an infant
JPGN Reports, EarlyView.Abstract Pyloric dysfunction is becoming increasingly recognized as a cause of gastroparesis, but its diagnostic and therapeutic role in infants has not been well studied. Identification and treatment of pyloric dysfunction with functional luminal imaging probe (FLIP) technology or use of pyloric inhibition are not routinely used in infants due to lack
Ariel Porto +3 more
wiley +1 more source
Botulinum toxin therapy: functional silencing of salivary disorders. [PDF]
, 2017 Botulinum toxin (BTX) is a neurotoxic protein produced by Clostridium botulinum, an anaerobic bacterium. BTX therapy is a safe and effective treatment when used for functional silencing of the salivary glands in disorders such as sialoceles and salivary ...
Lovato, A +4 more
core